Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

INDUSTRY 6OTHER 3NIH 2

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 22Genitourinary 12Tumor-Agnostic 8Gynecologic 8Other hematologic neoplasm 6Thoracic 5Gastrointestinal 4Other solid neoplasm 3Sarcoma 2CNS 2Plasma cell 1NET 1Myeloid 1Lymphoid 1Endocrine 1

Conditions

Triple Negative Metastatic Breast Cancer 1Mesothelioma, Malignant 1Childhood Solid Tumors 1

Interventions

Cisplatin 60Carboplatin 55Cyclophosphamide 47Pemetrexed 45Irinotecan 33pembrolizumab 32Paclitaxel 29Etoposide 29Gemcitabine 28Nivolumab 24Bevacizumab 24Interviews as Topic 23Vincristine 22Capecitabine 22Topotecan 20Filgrastim 20Early Intervention, Educational 20fludarabine 19Oxaliplatin 19Docetaxel 19Specimen Handling 18Drug Therapy 18Temozolomide 17Sorafenib 17Leucovorin 17Everolimus 17Educational Status 17Radiotherapy 16Methods 16Fluorouracil 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × talazoparib × Other solid neoplasm × Clear all
NCT02392793 2021-02-09

Talazoparib Plus Irinotecan With or Without Temozolomide in Children With Refractory or Recurrent Solid Malignancies

St. Jude Children's Research Hospital

Phase 1 Completed
43 enrolled
Other solid neoplasm

Childhood Solid Tumors

NCT04462809 2020-07-09

TALAMESO

Hospices Civils de Lyon

Phase 2 Unknown
40 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT02358200 2020-01-10

Study of BMN-673 With Carboplatin and Paclitaxel in Patients With Advanced BRCA-mutated Solid Tumor or Triple Negative Metastatic Breast Cancer

University of California, San Francisco

Phase 1 Terminated
23 enrolled
BreastOther solid neoplasm

Triple Negative Metastatic Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡